Inhibition of IL-1R1/MyD88 signalling promotes mesenchymal stem cell-driven tissue regeneration

Verfasser / Beitragende:
[Mikaël M. Martino, Kenta Maruyama, Gisela A. Kuhn, Takashi Satoh, Osamu Takeuchi, Ralph; id_orcid 0000-0002-5811-7725 Müller, Shizuo Akira]
Ort, Verlag, Jahr:
2016
Enthalten in:
Nature Communications, 7, p. 11051
Format:
Artikel (online)
ID: 528785648
LEADER caa a22 4500
001 528785648
005 20190713030954.0
007 cr unu---uuuuu
008 180924s2016 xx s 000 0 eng
024 7 0 |a 10.3929/ethz-b-000114095  |2 doi 
024 7 0 |a 10.1038/ncomms11051  |2 doi 
035 |a (ETHRESEARCH)oai:www.research-collecti.ethz.ch:20.500.11850/114095 
245 0 0 |a Inhibition of IL-1R1/MyD88 signalling promotes mesenchymal stem cell-driven tissue regeneration  |h [Elektronische Daten]  |c [Mikaël M. Martino, Kenta Maruyama, Gisela A. Kuhn, Takashi Satoh, Osamu Takeuchi, Ralph; id_orcid 0000-0002-5811-7725 Müller, Shizuo Akira] 
246 0 |a Nat Commun 
506 |a Open access  |2 ethresearch 
520 3 |a Tissue injury and the healing response lead to the release of endogenous danger signals including Toll-like receptor (TLR) and interleukin-1 receptor, type 1 (IL-1R1) ligands, which modulate the immune microenvironment. Because TLRs and IL-1R1 have been shown to influence the repair process of various tissues, we explored their role during bone regeneration, seeking to design regenerative strategies integrating a control of their signalling. Here we show that IL-1R1/MyD88 signalling negatively regulates bone regeneration, in the mouse. Furthermore, IL-1β which is released at the bone injury site, inhibits the regenerative capacities of mesenchymal stem cells (MSCs). Mechanistically, IL-1R1/MyD88 signalling impairs MSC proliferation, migration and differentiation by inhibiting the Akt/GSK-3β/β-catenin pathway. Lastly, as a proof of concept, we engineer a MSC delivery system integrating inhibitors of IL-1R1/MyD88 signalling. Using this strategy, we considerably improve MSC-based bone regeneration in the mouse, demonstrating that this approach may be useful in regenerative medicine applications. 
540 |a Creative Commons Attribution 4.0 International  |u http://creativecommons.org/licenses/by/4.0  |2 ethresearch 
700 1 |a Martino  |D Mikaël M.  |e joint author 
700 1 |a Maruyama  |D Kenta  |e joint author 
700 1 |a Kuhn  |D Gisela A.  |e joint author 
700 1 |a Satoh  |D Takashi  |e joint author 
700 1 |a Takeuchi  |D Osamu  |e joint author 
700 1 |a Müller  |D Ralph; id_orcid 0000-0002-5811-7725  |e joint author 
700 1 |a Akira  |D Shizuo  |e joint author 
773 0 |t Nature Communications  |d London : Nature Publishing Group  |g 7, p. 11051  |x 2041-1723 
856 4 0 |u http://hdl.handle.net/20.500.11850/114095  |q text/html  |z WWW-Backlink auf das Repository (Open access) 
908 |D 1  |a Journal Article  |2 ethresearch 
950 |B ETHRESEARCH  |P 856  |E 40  |u http://hdl.handle.net/20.500.11850/114095  |q text/html  |z WWW-Backlink auf das Repository (Open access) 
950 |B ETHRESEARCH  |P 700  |E 1-  |a Martino  |D Mikaël M.  |e joint author 
950 |B ETHRESEARCH  |P 700  |E 1-  |a Maruyama  |D Kenta  |e joint author 
950 |B ETHRESEARCH  |P 700  |E 1-  |a Kuhn  |D Gisela A.  |e joint author 
950 |B ETHRESEARCH  |P 700  |E 1-  |a Satoh  |D Takashi  |e joint author 
950 |B ETHRESEARCH  |P 700  |E 1-  |a Takeuchi  |D Osamu  |e joint author 
950 |B ETHRESEARCH  |P 700  |E 1-  |a Müller  |D Ralph; id_orcid 0000-0002-5811-7725  |e joint author 
950 |B ETHRESEARCH  |P 700  |E 1-  |a Akira  |D Shizuo  |e joint author 
950 |B ETHRESEARCH  |P 773  |E 0-  |t Nature Communications  |d London : Nature Publishing Group  |g 7, p. 11051  |x 2041-1723 
898 |a BK010053  |b XK010053  |c XK010000 
949 |B ETHRESEARCH  |F ETHRESEARCH  |b ETHRESEARCH  |j Journal Article  |c Open access